How do alternative regimens compare with monthly injection of anti-vascular endothelial growth factor agents for treating neovascular age-related macular degeneration (ARMD)?
2006 ◽
Vol 82
(1)
◽
pp. 99-110
◽
2017 ◽
Vol 23
(2)
◽
pp. 127-140
◽